[1]赵 磊,丁 语,徐伟洋,等.介入栓塞联合普萘洛尔治疗婴幼儿弥漫型肝血管瘤7例[J].介入放射学杂志,2023,32(09):861-865.
 ZHAO Lei,DING Yu,XU Weiyang,et al.Interventional embolization combined with propranolol for the treatment of diffuse infantile hepatic hemangioma: preliminary results in 7 cases[J].journal interventional radiology,2023,32(09):861-865.
点击复制

介入栓塞联合普萘洛尔治疗婴幼儿弥漫型肝血管瘤7例()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年09
页码:
861-865
栏目:
肿瘤介入
出版日期:
2023-09-27

文章信息/Info

Title:
Interventional embolization combined with propranolol for the treatment of diffuse infantile hepatic hemangioma: preliminary results in 7 cases
作者:
赵 磊 丁 语 徐伟洋 皮梦奇 徐 淼 范新东
Author(s):
ZHAO Lei DING Yu XU Weiyang PI Mengqi XU Miao FAN Xindong.
Department of Interventional Hemangioma and Vascular Surgery, Affiliated Children’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450018, China
关键词:
【关键词】 婴幼儿肝血管瘤 介入栓塞术 普萘洛尔 弥漫型
文献标志码:
A
摘要:
【摘要】 目的 探讨介入栓塞联合普萘洛尔治疗弥漫型婴幼儿肝血管瘤(IHH)的安全性和有效性。方法 回顾性分析7例弥漫型IHH患儿临床资料。采用介入栓塞联合口服普萘洛尔治疗方案。微导管超选择瘤体供血动脉,选用平阳霉素碘化油乳剂和聚乙烯醇(PVA)颗粒栓塞病灶,根据有无动静脉分流选择不同注射顺序,40%~50%病灶栓塞后停止栓塞,经肝固有动脉灌注平阳霉素稀释液。随访观察疗效、不良反应及并发症。 结果 7例弥漫型IHH患儿超选择性肝动脉栓塞术均获成功。术后口服普萘洛尔,逐渐增加剂量至2 mg/kg(2次/d)。术后随访5~14个月,4例完全缓解,2例部分缓解,总有效率为85.7%(6/7), 1例死亡。未发生与介入栓塞及普萘洛尔相关并发症。结论 介入栓塞联合口服普萘洛尔治疗弥漫型IHH安全有效。弥漫型IHH病情进展较快,建议在出现严重临床症状前尽早治疗。

参考文献/References:

[1] 中华医学会小儿外科学分会肝胆外科学组. 中华医学会小儿外科学分会肿瘤学组. 小儿肝血管瘤诊断和治疗专家共识[J]. 中华小儿外科杂志, 2020, 41:963- 970.
[2] Zavras N, Dimopoulou A, Machairas N, et al. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives[J]. Eur J Pediatr, 2020, 179: 1- 8.
[3] Jia K, Gao Z, Li M, et al. Interventional treatments for hepatic hemangioma: a state- of- the- art review[J]. J Interv Med, 2022, 5: 6- 9.
[4] Kulungowski AM, Alomari AI, Chawla A, et al. Lessons from a liver hemangioma registry: subtype classification[J]. J Pediatr Surg, 2012, 47: 165- 170.
[5] Zhang XT,Ren WD,Song G,et al. Infantile hepatic hemangiomas associated with high- output cardiac failure and pulmonary hypertension[J]. BMC Cardiovasc Disord, 2019, 19: 216.
[6] Lerut J, Iesari S. Vascular tumours of the liver: a particular story[J]. Transl Gastroenterol Hepatol, 2018, 3: 62.
[7] Kulungowski AM,Alomari AI,Chawla A,et al. Lessons from a liver hemangioma registry: subtype classification[J]. J Pediatr Surg, 2012, 47: 165- 170.
[8] 姚 伟,李 凯,董岿然,等. 婴幼儿肝血管瘤82例分类特点及疗效分析[J]. 中华小儿外科杂志, 2018, 39:739- 743.
[9] Wang L, Li J, Song D, et al. Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma[J]. Pediatr Surg Int, 2022, 38: 1149- 1155.
[10] Rialon KL,Murillo R,Fevurly RD,et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas[J]. J Pediatr Surg, 2015, 50: 837- 841.
[11] 韩立玲,章 均,朱 进,等. 单中心儿童肝血管瘤诊治经验的回顾性分析研究[J]. 中华小儿外科杂志, 2020, 41:982- 988.
[12] Avagyan S,Klein M,Kerkar N,et al. Propranolol as a first- line treatment for diffuse infantile hepatic hemangioendothelioma[J]. J Pediatr Gastroenterol Nutr, 2013, 56: e17- e20.
[13] Hernández F, Navarro M, Encinas JL, et al. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children[J]. J Pediatr Surg, 2005, 40: 801- 804.
[14] Iacobas I,Phung TL,Adams DM,et al. Guidance document for hepatic hemangioma(infantile and congenital) evaluation and monitoring[J]. J Pediatr, 2018, 203: 294- 300.e2.
[15] Christison- Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry[J]. J Pediatr Surg, 2007, 42: 62- 67.
[16] Gnarra M,Behr G,Kitajewski A,et al. History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis[J]. World J Clin Pediatr, 2016, 5: 273- 280.
[17] Isaacs H Jr. Fetal and neonatal hepatic tumors[J]. J Pediatr Surg, 2007, 42: 1797- 1803.
[18] Ji Y, Chen S, Yang K, et al. Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: a multicenter prospective study[J]. J Am Acad Dermatol, 2021, 84: 1378- 1384.
[19] 杨开颖,彭素华. 婴幼儿肝血管瘤诊治现状[J]. 临床小儿外科杂志, 2020, 19:746- 751.
[20] Kuroda T,Kumagai M,Nosaka S,et al. Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group[J]. J Pediatr Surg, 2011, 46: 2239- 2243.
[21] Rialon KL, Murillo R, Fevurly RD, et al. Impact of screening for hepatic hemangiomas in patients with multiple cutaneous infantile hemangiomas[J]. Pediatr Dermatol, 2015, 32: 808- 812.
[22] Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease[J]. Nat Rev Cardiol, 2017, 14: 39- 55.
[23] Ernst L, Grabhorn E, Brinkert F, et al. Infantile hepatic hemangioma: avoiding unnecessary invasive procedures[J]. Pediatr Gastroenterol Hepatol Nutr, 2020, 23: 72- 78.
[24] 阴 捷,王 驰,刘 玥. 肝血管内皮细胞瘤伴动静脉分流的影像学表现与介入治疗疗效评估[J]. 中华普通外科杂志, 2019, 34:689- 692.
[25] 顾祝新,黄 健,赵苏鸣,等. 3种介入栓塞材料治疗巨大肝血管瘤临床效果比较[J]. 介入放射学杂志, 2019, 28:324- 327.
[26] 王文静,刘博策,毕见海,等. 超声引导下平阳霉素联合聚桂醇硬化治疗94例囊性淋巴管畸形的疗效[J]. 山东大学学报(医学版), 2022, 60:72- 78.
[27] 孔 鹏,鹿化伟,王家平,等. 平阳霉素碘油乳剂超选择硬化性栓塞治疗肝血管瘤[J]. 介入放射学杂志, 2011, 20:123- 126.

相似文献/References:

[1]李俊君,路 华.不同介入栓塞技术对前交通动脉瘤破裂患者认知功能的影响[J].介入放射学杂志,2016,(05):374.
 LI Jun- jun,LU Hua.The influence of different interventional embolization techniques on the cognitive function of patients with ruptured anterior communicating artery aneurysm[J].journal interventional radiology,2016,(09):374.
[2]刘东辉,李志强,鄂亚军.颅内动脉瘤血管内介入栓塞术中再次破裂出血紧急处置 [J].介入放射学杂志,2017,(06):486.
 LIU Donghui,LI Zhiqiang,E Yajun..Emergency management of intraoperative re- rupture of intracranial aneurysm with bleeding during endovascular interventional embolization procedure[J].journal interventional radiology,2017,(09):486.
[3]曹治列,符 二,曹俊雄,等.血管塞与弹簧圈联合介入栓塞治疗精索静脉曲张[J].介入放射学杂志,2024,33(01):73.
 CAO Zhilie,FU Er,CAO Junxiong,et al.Interventional embolization using vascular plug together with spring coil for the treatment of varicocele[J].journal interventional radiology,2024,33(09):73.

备注/Memo

备注/Memo:
(收稿日期:2022- 11- 14)
(本文编辑:谷 珂)
更新日期/Last Update: 2023-09-26